Literature DB >> 8041753

Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation.

S M Greenberg1, E H Koo, D J Selkoe, W Q Qiu, K S Kosik.   

Abstract

Biological effects related to cell growth, as well as a role in the pathogenesis of Alzheimer disease, have been ascribed to the beta-amyloid precursor protein (beta-APP). Little is known, however, about the intracellular cascades that mediate these effects. We report that the secreted form of beta-APP potently stimulates mitogen-activated protein kinases (MAPKs). Brief exposure of PC-12 pheochromocytoma cells to beta-APP secreted by transfected Chinese hamster ovary cells stimulated the 43-kDa form of MAPK by > 10-fold. Induction of a dominant inhibitory form of ras in a PC12-derived cell line prevented the stimulation of MAPK by secreted beta-APP, demonstrating the dependence of the effect upon p21ras. Because the microtubule-associated protein tau is hyperphosphorylated in Alzheimer disease, we sought and found a 2-fold enhancement in tau phosphorylation associated with the beta-APP-induced MAPK stimulation. In the ras dominant inhibitory cell line, beta-APP failed to enhance phosphorylation of tau. The data presented here provide a link between secreted beta-APP and the phosphorylation state of tau.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041753      PMCID: PMC44347          DOI: 10.1073/pnas.91.15.7104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Amyloid beta protein enhances the survival of hippocampal neurons in vitro.

Authors:  J S Whitson; D J Selkoe; C W Cotman
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

2.  Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts.

Authors:  T Saitoh; M Sundsmo; J M Roch; N Kimura; G Cole; D Schubert; T Oltersdorf; D B Schenk
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

3.  The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.

Authors:  T Oltersdorf; L C Fritz; D B Schenk; I Lieberburg; K L Johnson-Wood; E C Beattie; P J Ward; R W Blacher; H F Dovey; S Sinha
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

4.  Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor.

Authors:  W E Van Nostrand; S L Wagner; M Suzuki; B H Choi; J S Farrow; J W Geddes; C W Cotman; D D Cunningham
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

5.  p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected].

Authors:  M Goedert; E S Cohen; R Jakes; P Cohen
Journal:  FEBS Lett       Date:  1992-11-02       Impact factor: 4.124

6.  Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage.

Authors:  A Y Hung; E H Koo; C Haass; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat.

Authors:  D T Stephenson; K Rash; J A Clemens
Journal:  Brain Res       Date:  1992-10-09       Impact factor: 3.252

8.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

Authors:  A Weidemann; G König; D Bunke; P Fischer; J M Salbaum; C L Masters; K Beyreuther
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

9.  Sodium-phosphate cotransport in human red blood cells. Kinetics and role in membrane metabolism.

Authors:  D G Shoemaker; C A Bender; R B Gunn
Journal:  J Gen Physiol       Date:  1988-10       Impact factor: 4.086

10.  Epitopes that span the tau molecule are shared with paired helical filaments.

Authors:  K S Kosik; L D Orecchio; L Binder; J Q Trojanowski; V M Lee; G Lee
Journal:  Neuron       Date:  1988-11       Impact factor: 17.173

View more
  30 in total

Review 1.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

Review 2.  Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases.

Authors:  G Brent Irvine; Omar M El-Agnaf; Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

3.  The pool of map kinase associated with microtubules is small but constitutively active.

Authors:  M Morishima-Kawashima; K S Kosik
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

4.  From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells.

Authors:  C U Pietrzik; J Hoffmann; K Stöber; C Y Chen; C Bauer; D A Otero; J M Roch; V Herzog
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 5.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

6.  Local and Use-Dependent Effects of β-Amyloid Oligomers on NMDA Receptor Function Revealed by Optical Quantal Analysis.

Authors:  Brooke L Sinnen; Aaron B Bowen; Emily S Gibson; Matthew J Kennedy
Journal:  J Neurosci       Date:  2016-11-09       Impact factor: 6.167

Review 7.  Biomarkers in Alzheimer's disease: past, present and future.

Authors:  Katarzyna Gustaw-Rothenberg; Alan Lerner; David J Bonda; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

8.  Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells.

Authors:  Z W Hu; X Y Shi; B B Hoffman
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 9.  Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds.

Authors:  Cristobal de Los Rios; Maria F Cano-Abad; Mercedes Villarroya; Manuela G López
Journal:  Pflugers Arch       Date:  2017-08-19       Impact factor: 3.657

Review 10.  Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle.

Authors:  Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.